vs
CLOVER HEALTH INVESTMENTS, CORP.（CLOV）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
CLOVER HEALTH INVESTMENTS, CORP.的季度营收约是LifeStance Health Group, Inc.的1.3倍（$487.7M vs $382.2M），LifeStance Health Group, Inc.净利率更高（3.1% vs -10.1%，领先13.2%），CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（44.7% vs 17.4%），LifeStance Health Group, Inc.自由现金流更多（$46.6M vs $-69.0M），过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（18.6% vs 12.8%）
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
CLOV vs LFST — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $487.7M | $382.2M |
| 净利润 | $-49.3M | $11.7M |
| 毛利率 | — | — |
| 营业利润率 | -10.1% | 4.7% |
| 净利率 | -10.1% | 3.1% |
| 营收同比 | 44.7% | 17.4% |
| 净利润同比 | -123.2% | 264.1% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $487.7M | $382.2M | ||
| Q3 25 | $496.6M | $363.8M | ||
| Q2 25 | $477.6M | $345.3M | ||
| Q1 25 | $462.3M | $333.0M | ||
| Q4 24 | $337.0M | $325.5M | ||
| Q3 24 | $331.0M | $312.7M | ||
| Q2 24 | $356.3M | $312.3M | ||
| Q1 24 | $346.9M | $300.4M |
| Q4 25 | $-49.3M | $11.7M | ||
| Q3 25 | $-24.4M | $1.1M | ||
| Q2 25 | $-10.6M | $-3.8M | ||
| Q1 25 | $-1.3M | $709.0K | ||
| Q4 24 | $-22.1M | $-7.1M | ||
| Q3 24 | $-9.2M | $-6.0M | ||
| Q2 24 | $7.4M | $-23.3M | ||
| Q1 24 | $-19.2M | $-21.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 24.5% | — | ||
| Q2 24 | 30.3% | — | ||
| Q1 24 | 23.6% | — |
| Q4 25 | -10.1% | 4.7% | ||
| Q3 25 | -4.9% | 2.0% | ||
| Q2 25 | -2.2% | -0.9% | ||
| Q1 25 | -0.3% | 0.5% | ||
| Q4 24 | -6.4% | 0.3% | ||
| Q3 24 | -2.7% | 0.0% | ||
| Q2 24 | 2.0% | -5.1% | ||
| Q1 24 | -6.5% | -5.6% |
| Q4 25 | -10.1% | 3.1% | ||
| Q3 25 | -4.9% | 0.3% | ||
| Q2 25 | -2.2% | -1.1% | ||
| Q1 25 | -0.3% | 0.2% | ||
| Q4 24 | -6.6% | -2.2% | ||
| Q3 24 | -2.8% | -1.9% | ||
| Q2 24 | 2.1% | -7.5% | ||
| Q1 24 | -5.5% | -7.0% |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.3M | $248.6M |
| 总债务越低越好 | — | $282.8M |
| 股东权益账面价值 | $308.7M | $1.5B |
| 总资产 | $541.0M | $2.2B |
| 负债/权益比越低杠杆越低 | — | 0.19× |
8季度趋势，按日历期对齐
| Q4 25 | $78.3M | $248.6M | ||
| Q3 25 | — | $203.9M | ||
| Q2 25 | — | $188.9M | ||
| Q1 25 | — | $134.3M | ||
| Q4 24 | $194.5M | $154.6M | ||
| Q3 24 | $288.0M | $102.6M | ||
| Q2 24 | $254.8M | $87.0M | ||
| Q1 24 | $208.3M | $49.5M |
| Q4 25 | — | $282.8M | ||
| Q3 25 | — | $284.6M | ||
| Q2 25 | — | $286.4M | ||
| Q1 25 | — | $288.2M | ||
| Q4 24 | — | $290.0M | ||
| Q3 24 | — | $287.3M | ||
| Q2 24 | — | $288.0M | ||
| Q1 24 | — | $288.8M |
| Q4 25 | $308.7M | $1.5B | ||
| Q3 25 | $340.9M | $1.5B | ||
| Q2 25 | $344.2M | $1.5B | ||
| Q1 25 | $336.1M | $1.5B | ||
| Q4 24 | $341.1M | $1.4B | ||
| Q3 24 | $342.2M | $1.4B | ||
| Q2 24 | $324.9M | $1.4B | ||
| Q1 24 | $292.5M | $1.4B |
| Q4 25 | $541.0M | $2.2B | ||
| Q3 25 | $559.7M | $2.1B | ||
| Q2 25 | $575.0M | $2.1B | ||
| Q1 25 | $583.7M | $2.1B | ||
| Q4 24 | $580.7M | $2.1B | ||
| Q3 24 | $653.0M | $2.1B | ||
| Q2 24 | $674.2M | $2.1B | ||
| Q1 24 | $671.8M | $2.1B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-66.9M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $-69.0M | $46.6M |
| 自由现金流率自由现金流/营收 | -14.1% | 12.2% |
| 资本支出强度资本支出/营收 | 0.4% | 2.9% |
| 现金转化率经营现金流/净利润 | — | 4.93× |
| 过去12个月自由现金流最近4个季度 | $-69.2M | $110.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-66.9M | $57.6M | ||
| Q3 25 | $12.1M | $27.3M | ||
| Q2 25 | $5.4M | $64.4M | ||
| Q1 25 | $-16.3M | $-3.1M | ||
| Q4 24 | $34.8M | $62.3M | ||
| Q3 24 | $50.0M | $22.7M | ||
| Q2 24 | $44.8M | $44.1M | ||
| Q1 24 | $25.9M | $-21.8M |
| Q4 25 | $-69.0M | $46.6M | ||
| Q3 25 | $11.4M | $17.0M | ||
| Q2 25 | $4.8M | $56.6M | ||
| Q1 25 | $-16.5M | $-10.3M | ||
| Q4 24 | $33.3M | $56.0M | ||
| Q3 24 | $49.6M | $17.7M | ||
| Q2 24 | $44.4M | $39.0M | ||
| Q1 24 | $25.5M | $-26.9M |
| Q4 25 | -14.1% | 12.2% | ||
| Q3 25 | 2.3% | 4.7% | ||
| Q2 25 | 1.0% | 16.4% | ||
| Q1 25 | -3.6% | -3.1% | ||
| Q4 24 | 9.9% | 17.2% | ||
| Q3 24 | 15.0% | 5.7% | ||
| Q2 24 | 12.5% | 12.5% | ||
| Q1 24 | 7.3% | -9.0% |
| Q4 25 | 0.4% | 2.9% | ||
| Q3 25 | 0.1% | 2.8% | ||
| Q2 25 | 0.1% | 2.2% | ||
| Q1 25 | 0.0% | 2.2% | ||
| Q4 24 | 0.5% | 1.9% | ||
| Q3 24 | 0.1% | 1.6% | ||
| Q2 24 | 0.1% | 1.6% | ||
| Q1 24 | 0.1% | 1.7% |
| Q4 25 | — | 4.93× | ||
| Q3 25 | — | 25.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 6.04× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
